Ocular Hypertension clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Clarifying the Optimal Application of SLT Therapy Trial

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 18 years and up

    The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.

    at UC Davis UCLA UCSF

  • Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

    Sorry, in progress, not accepting new patients

    This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR or who received commercial DURYSTA (Bimatoprost SR) in the open-label Phase 4 ARGOS study (MED-MA-EYE-0648) and completed (or exited early from) the study.

    at UCSD

Our lead scientists for Ocular Hypertension research studies include .

Last updated: